Search

New Targeted Therapy for Patients with Metastatic Triple-Negative Breast Cancer

People with triple-negative breast cancer (TNBC) that has spread to other parts of the body (metastatic) now have a new treatment option called Trodelvy (sacituzumab govitecan-hziy). This drug was recently ...

Tazverik: Approved for Advanced Epithelioid Sarcoma and Follicular Lymphoma

Last year, the anticancer drug Tazverik (tazemetostat) received approval for use in the treatment of 2 malignancies.

Anything But Routine: Fertility Preservation Story of Hope

Megan Solinger, MHS, MA, OPN-CG, talks about the hard lessons she’s learned as a patient navigator and the amazing results of her first experience as a fertility preservation navigator.

Tukysa Improves Survival in Patients with HER2-Positive Breast Cancer that Has Spread to the Brain

The new cancer drug Tukysa (tucatinib), when given in combination with Herceptin (trastuzumab) and capecitabine, dramatically improved outcomes for patients with HER2-positive advanced breast cancer that ...

Sex During a Cancer Diagnosis and Treatment: What You Need to Know: Interview with Daniel Vorobiof, MD

Dr. Daniel Vorobiof, an oncologist and an expert on sexuality, addresses some of the common misconceptions about sexuality during cancer treatment and offers strategies for dealing with the changes that ...

Proton Therapy Improves Outcomes, Reduces Radiation Side Effects in Patients with Cancer

Proton therapy has advantages over traditional radiation in reducing radiation side effects and improving patient outcomes. However, many patients and their oncologists are not familiar with this newer ...

Surviving Pregnancy and Breast Cancer

With her family history of cancers related to the BRCA mutation, Jamie Ledezma’s first pregnancy suddenly got very complicated when she learned she had triple-negative breast cancer.

Breast Cancer Under 40: The Impact on Young Patients

An encouraging story of survival from a breast cancer nurse navigator who is also a breast cancer survivor.

Making Sure Your Treatment Team Stays Connected

One of the many things that you probably did after receiving a diagnosis of multiple myeloma was to select a doctor and care team. They helped you to learn about multiple myeloma and how to navigate the ...

Public Health Professional Turned Patient: The Lives We Save May Be Our Own

Sheree Williams, PhD, is a health scientist with the CDC, but her background in public health did not prepare her for the unique challenges she faced as a black woman diagnosed with breast cancer, highlighting ...

What Your Doctor Should Know: Which Treatment Is Best for a Patient with Relapsed or Refractory Multiple Myeloma?

Many medications for multiple myeloma have been approved in recent years. That is great for patients, but it becomes even more important that doctors choose the best treatment for each patient.

Is Cancer Rehabilitation a Good Option for You? It’s Never Too Late to Ask for a Referral

Many patients with cancer and cancer survivors suffer from pain and impaired functioning as a result of cancer treatment, even years after the treatment is over. Nevertheless, only a few people receive ...

Why Target the Immune System?

The immune system attacks foreign substances by making large numbers of antibodies. These are proteins that attach to a specific protein on the cell called an antigen.

My Family’s Love Is the Reason I Fight

Melody recounts her story of being a 34-year-old new mother diagnosed with breast cancer.

Patient Perspectives in Multiple Myeloma

Highlights from the 2018 American Society of Hematology Annual Meeting

Making Sure Your Treatment Team Stays Connected

Patient Advocates Jack Aiello and Nancy Kaufmann stress the importance of communication and share tips to stay in sync with the treatment team.

Cancer Genetics or Genomics — Is There a Difference?

The terms genetics and genomics are often used interchangeably in relation to cancer, but they refer to different things and are becoming very important in cancer treatment.

Never Say Never: How I Beat the Odds

After achieving remission of stage IV Hodgkin lymphoma, Sydney was told she would have less than a 5% chance of conception because of the treatment she received. Then 2 miracles happened.

A Fashion Model Finds Her Voice to Speak About Her Cancer Experience

“The first thing I said was, there’s no way. I consider myself the healthiest person I know. There’s nothing that I did that could have caused cancer,” Rachelle said. “I was just in complete shock.”

What to Consider When You Are Diagnosed with Follicular Lymphoma

Dr. Stevens, of the Norton Cancer Institute in Louisville, KY, provides an in-depth overview of what to expect with a Follicular Lymphoma diagnosis.

Search

Subscribe Today!